Your browser doesn't support javascript.
loading
The impact of the bluetongue serotype 3 outbreak on sheep and goat mortality in the Netherlands in 2023.
Santman-Berends, I M G A; van den Brink, K M J A; Dijkstra, E; van Schaik, G; Spierenburg, M A H; van den Brom, R.
Affiliation
  • Santman-Berends IMGA; Department of Research and Development, Royal GD, Deventer, the Netherlands. Electronic address: I.Santman@gddiergezondheid.nl.
  • van den Brink KMJA; Department of Cattle Health, Royal GD, Deventer, the Netherlands.
  • Dijkstra E; Department of Small Ruminant Health, Royal GD, Deventer, the Netherlands.
  • van Schaik G; Department of Research and Development, Royal GD, Deventer, the Netherlands; Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
  • Spierenburg MAH; Dutch Food and Consumer Product Safety Authority (NVWA), Utrecht, the Netherlands.
  • van den Brom R; Department of Small Ruminant Health, Royal GD, Deventer, the Netherlands.
Prev Vet Med ; 231: 106289, 2024 Jul 19.
Article in En | MEDLINE | ID: mdl-39126984
ABSTRACT
In September 2023, bluetongue virus serotype 3 (BTV-3) emerged in the Netherlands, infecting over five thousand livestock farms. In sheep, high morbidity and mortality rates were reported that were unlike previously described bluetongue outbreaks. This study aimed to quantify the impact of BTV-3 in the small ruminant population in the Netherlands in 2023. Sheep and goat movement census data and BTV-3 notification data were available from 2020 until the end of 2023. Data were aggregated to farm and week level and mortality indicators were calculated for lambs (<1 year) and adult animals (≥1 year). Population averaged GEE models with a Negative-binomial distribution and a log-link function correcting for repeated measures per farm in time were used to quantify the association between BTV-3 and mortality. In 2023, 2994 sheep farmers and 89 goat farmers notified clinical signs of BTV-3 to the NVWA. During this BTV-3 outbreak period, an additional 55,000 sheep died compared to the same period in 2020-2022. At flock level a high variety in mortality was observed, with a clear increase in mortality in both flocks that were not notified but that were located in infected areas and in flocks of which the farmer notified clinical signs. During the BTV-3 outbreak period, mortality in infected areas increased 4.2 (95 % CI 4.0-4.3) times in sheep lambs (<1 year) and 4.6 (95 % CI 4.4-4.8) times in sheep (≥1 year) compared to BTV-3 free areas. Flocks with a confirmed BTV-3 infection that were notified in September showed a 12.8 (95 % CI 11.4-14.3) times higher mortality in lambs and a 15.1 (95 % CI 13.7-16.6) times higher mortality in sheep compared to flocks in BTV-3 areas. In flocks of which the farmer notified clinical signs after September, mortality was 4.6 (95 % CI 4.2-5.0) and 5.6 (95 % CI 5.1-6.0) times higher in lambs and sheep compared BTV-3 areas respectively. In goats, around 4000 additional deaths were recorded during the BTV-3 outbreak period. In farms that were notified, mortality of goats (≥1 year) was 1.8 (95 % CI 1.2-2.8) times higher compared to BTV-3 free areas. Since May 2024, multiple BTV-3 vaccines are available in the Netherlands. In June 2024, the first new infections of BTV-3 were confirmed in Dutch sheep flocks. Hopes are that with the possibility to vaccinate, the spread and impact of BTV-3 in the Netherlands will rapidly decline and that losses as observed in 2023 will no longer be seen.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Prev Vet Med Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Prev Vet Med Year: 2024 Document type: Article